Cyclophosphamide, methotrexate, and cytarabine embropathy: is apoptosis the common pathway?
about
Oxidative stress, unfolded protein response, and apoptosis in developmental toxicityAnti-inflammatory and immunosuppressive drugs and reproductionHuman pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing dataCyclophosphamide for lupus during pregnancy.Fetal Renal Insufficiency Following Trastuzumab Treatment for Breast Cancer in Pregnancy: Case Report und Review of the Current Literature.Cancer chemotherapeutic agents as human teratogens.Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of management.High-risk pregnancy and the rheumatologist.Exploring the safety of chemotherapy for treating breast cancer during pregnancy.Linear-No-Threshold Default Assumptions are Unwarranted for Cytotoxic Endpoints Independently Triggered by Ultrasensitive Molecular Switches.Prematurity and neonatal outcome including congenital malformations after maternal malignancy within six months prior to or during pregnancy.Antimutagenic Effects of Selenium-Enriched Polysaccharides from Pyracantha fortuneana through Suppression of Cytochrome P450 1A Subfamily in the Mouse Liver.Klippel-Feil syndrome in a boy exposed inadvertently to cyclophosphamide during pregnancy: a case report.Early embryonic sensitivity to cyclophosphamide in cardiac differentiation from human embryonic stem cells.
P2860
Q28084613-09CD8D58-AF5E-4791-A31D-04A3DB552AFFQ28218219-EA021B2B-7574-4FC4-8E62-E442FB8E1EB8Q31044246-2A7FF39D-3C2D-49BC-8693-B7D36A15653DQ33368551-CEE33B19-511F-4216-8D7A-5C21CD7757A6Q35789387-0959C1AC-FBFE-48AA-A303-A7673DCCAC1EQ38031187-30C0A893-32F5-4A35-BD67-9F74B4F02795Q38254406-CC9AD8AA-C3ED-45D8-9487-0F541890F740Q38283472-73E44436-36B4-45C1-AA3B-D149D786D495Q38539265-51FC15D5-D723-4DC1-9EF8-AC1BE2DC50CCQ38822585-763B5A42-68A9-4E9A-B69E-357B1215399AQ48290421-76415EE3-5787-4BE3-BBC9-A5EE3AE1C7EFQ48893179-CD784B76-29C6-4C74-A3B8-B38663EB7CD5Q51799336-0338471B-C806-494C-A326-176C9D5091BAQ51867792-C6F8CE02-82D0-4345-9B98-91A42FAA465B
P2860
Cyclophosphamide, methotrexate, and cytarabine embropathy: is apoptosis the common pathway?
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cyclophosphamide, methotrexate ...... apoptosis the common pathway?
@ast
Cyclophosphamide, methotrexate ...... apoptosis the common pathway?
@en
Cyclophosphamide, methotrexate ...... apoptosis the common pathway?
@nl
type
label
Cyclophosphamide, methotrexate ...... apoptosis the common pathway?
@ast
Cyclophosphamide, methotrexate ...... apoptosis the common pathway?
@en
Cyclophosphamide, methotrexate ...... apoptosis the common pathway?
@nl
prefLabel
Cyclophosphamide, methotrexate ...... apoptosis the common pathway?
@ast
Cyclophosphamide, methotrexate ...... apoptosis the common pathway?
@en
Cyclophosphamide, methotrexate ...... apoptosis the common pathway?
@nl
P2093
P356
P1476
Cyclophosphamide, methotrexate ...... apoptosis the common pathway?
@en
P2093
Keith K Vaux
Kenneth Lyons Jones
Nathanial C O Kahole
P2860
P304
P356
10.1002/BDRA.10060
P577
2003-06-01T00:00:00Z